ARX vs AVE

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

56MEDIUM

AVE

AVECHO FPO [AVE]

55MEDIUM

Score Breakdown

ARX AVE
Technical
48
55
Catalyst
55
59
Sentiment
50
50
Fundamental
99
44
Momentum
46
71
Risk Gate
50
45

Key Metrics

ARX Metric AVE
$191.1MMarket Cap$77.3M
144KAvg Volume (20d)3.9M
N/AShort InterestN/A
$0.80052-Week High$0.027
$0.49552-Week Low$0.005
+0.0%Daily Change-4.6%
$0.540Reference Price$0.021
+4.9%ROE-268.2%
+4.5%Profit MarginN/A

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 4.4% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it

AVE Signals

●Drifting lower — down 8.7% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (7 quarters)
●Very high P/S ratio (104.8x)
●Revenue in sharp decline (-89%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)

Ask Scout AI to compare ARX and AVE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs DOC →ARX vs SOM →ATX vs AVE →ATX vs DOC →ATX vs SOM →
ARX Full Analysis → AVE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).